Analyst Consensus ?
ConsensusBuy64 ratings
Bullish5484.4%
Neutral69.4%
Bearish46.2%
FN2 Earnings Intelligence
Slb N.V. analyst ratings
Slb N.V. (SLB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$50.7Current
$42Low
$57.2Average
$81High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Jul 27, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 10, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 8, 2026 |
| UBS | Buy | Buy | Maintain | Jul 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 1, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 18, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 16, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jun 10, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 11, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 15, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 15, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| Freedom Broker | Sell | Hold | Downgrade | Jan 27, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 26, 2026 |
| Freedom Capital Markets | Hold | Buy | Downgrade | Jan 6, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 5, 2025 |
| Benchmark | Buy | Buy | Maintain | Jul 22, 2024 |
| HSBC | Buy | Buy | Maintain | Apr 4, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jan 12, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 25, 2022 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 26, 2022 |
| Oddo Securities | Outperform | Outperform | Maintain | Oct 14, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 26, 2021 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 19, 2020 |
| Northland Capital Markets | Outperform | Outperform | Maintain | May 29, 2020 |
| CFRA | Sell | Hold | Downgrade | Mar 9, 2020 |
| Tudor Pickering | Buy | Sell | Upgrade | Nov 20, 2019 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 20, 2019 |
| Gabelli & Co. | Buy | Buy | Maintain | Jun 27, 2019 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Jun 7, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Apr 3, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Feb 26, 2018 |
| Griffin Securities | Buy | Neutral | Upgrade | Feb 12, 2018 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jan 22, 2018 |
| Loop Capital | Buy | Buy | Maintain | Oct 26, 2017 |
| Guggenheim | Neutral | Buy | Downgrade | Jun 27, 2017 |
| Nomura | Buy | Buy | Maintain | Aug 16, 2016 |
| Societe Generale | Buy | Hold | Upgrade | Jul 19, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Outperform | Maintain | May 12, 2016 |
| Standpoint Research | Hold | Buy | Downgrade | Apr 20, 2016 |
| DA Davidson | Buy | Buy | Maintain | Feb 19, 2016 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 7, 2016 |
| GMP Securities | Buy | Buy | Maintain | Jan 5, 2016 |
| William Blair | Outperform | Market Perform | Upgrade | Dec 18, 2015 |
| KLR Group | Buy | Buy | Maintain | Dec 14, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 21, 2015 |
| Macquarie | Neutral | Neutral | Maintain | Sep 9, 2015 |
| Seaport Global | Buy | Neutral | Upgrade | Jul 20, 2015 |
| CLSA | Underperform | Buy | Downgrade | Apr 20, 2015 |
| Baird | Outperform | Outperform | Maintain | Apr 19, 2015 |
| RS Platou Markets | Sell | Neutral | Downgrade | Jan 20, 2015 |
| ISI Group | Buy | Buy | Maintain | Oct 16, 2014 |
| IBERIA Capital Partners | Outperform | Sector Perform | Upgrade | Sep 25, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jun 20, 2014 |
| Argus Research | Buy | Buy | Maintain | Apr 29, 2014 |
| Johnson Rice | Overweight | Equal Weight | Upgrade | Jan 21, 2014 |
| Global Hunter Securities | Buy | Neutral | Upgrade | Jul 22, 2013 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 3, 2012 |
| Dahlman Rose | Buy | Buy | Maintain | Mar 30, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $50.7. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $66 | $52.42 | +30.2% | Jul 27, 2026 |
| Susquehanna | Charles Minervino | $62 | $52.42 | +22.3% | Jul 27, 2026 |
| Piper Sandler | Analyst unavailable | $64 | $52.42 | +26.2% | Jul 27, 2026 |
| Barclays | David Anderson | $67 | $52.42 | +32.1% | Jul 27, 2026 |
| Jefferies | Analyst unavailable | $66 | $52.42 | +30.2% | Jul 26, 2026 |
| Barclays | Analyst unavailable | $64 | $47.55 | +26.2% | Jul 16, 2026 |
| Morgan Stanley | Joe Laetsch | $54 | $47.83 | +6.5% | Jul 15, 2026 |
| Raymond James | Analyst unavailable | $61 | $47.94 | +20.3% | Jul 10, 2026 |
| Wolfe Research | Carlos Escalante | $62 | $47.1 | +22.3% | Jul 8, 2026 |
| Susquehanna | Charles Minervino | $55 | $47.19 | +8.5% | Jul 8, 2026 |
| UBS | Analyst unavailable | $66 | $45.54 | +30.2% | Jul 1, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $64 | $50.33 | +26.2% | Jun 18, 2026 |
| Bernstein | Analyst unavailable | $71 | $53.27 | +40.0% | May 11, 2026 |
| Barclays | Analyst unavailable | $66 | $55.16 | +30.2% | May 7, 2026 |
| Susquehanna | Charles Minervino | $65 | $55.58 | +28.2% | Apr 27, 2026 |
| BMO Capital | Phillip Jungwirth | $63 | $55.56 | +24.3% | Apr 27, 2026 |
| Morgan Stanley | Analyst unavailable | $57 | $55.84 | +12.4% | Apr 27, 2026 |
| Evercore ISI | Analyst unavailable | $64 | $56.15 | +26.2% | Apr 27, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $61 | $56.15 | +20.3% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $51 | $56.15 | +0.6% | Apr 27, 2026 |
| Jefferies | Analyst unavailable | $65 | $56.15 | +28.2% | Apr 26, 2026 |
| Morgan Stanley | Joe Laetsch | $55 | $51.49 | +8.5% | Apr 15, 2026 |
| Piper Sandler | Analyst unavailable | $59 | $51.49 | +16.4% | Apr 15, 2026 |
| Jefferies | Analyst unavailable | $58 | $48.38 | +14.4% | Feb 1, 2026 |
| Loop Capital Markets | Sergey Pigarev | $48 | $50.31 | -5.3% | Jan 27, 2026 |
| UBS | Josh Silverstein | $61 | $50.46 | +20.3% | Jan 27, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $56 | $49.32 | +10.5% | Jan 26, 2026 |
| Susquehanna | Analyst unavailable | $58 | $49.66 | +14.4% | Jan 26, 2026 |
| RBC Capital | Keith Mackey | $54 | $49.58 | +6.5% | Jan 26, 2026 |
| UBS | Analyst unavailable | $54 | $49.88 | +6.5% | Jan 26, 2026 |
| BMO Capital | Analyst unavailable | $55 | $49.15 | +8.5% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $49 | $49.15 | -3.4% | Jan 26, 2026 |
| Morgan Stanley | Analyst unavailable | $50 | $47.76 | -1.4% | Jan 21, 2026 |
| RBC Capital | Keith Mackey | $51 | $46.78 | +0.6% | Jan 15, 2026 |
| Goldman Sachs | Neil Mehta | $49 | $45.9 | -3.4% | Jan 14, 2026 |
| Susquehanna | Analyst unavailable | $52 | $42.89 | +2.6% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $54 | $43.8 | +6.5% | Jan 6, 2026 |
| Piper Sandler | Analyst unavailable | $45 | $38.53 | -11.2% | Dec 18, 2025 |
| Barclays | David Anderson | $47 | $37.61 | -7.3% | Dec 17, 2025 |
| UBS | Analyst unavailable | $50 | $39.48 | -1.4% | Dec 12, 2025 |
| Cowen & Co. | Analyst unavailable | $57 | $40.67 | +12.4% | Dec 11, 2025 |
| Bernstein | Guillaume Delaby | $52.3 | $39.94 | +3.2% | Dec 11, 2025 |
| Redburn Partners | Sebastian Erskine | $48 | $36.06 | -5.3% | Nov 3, 2025 |
| UBS | Josh Silverstein | $44 | $33.64 | -13.2% | Oct 21, 2025 |
| Piper Sandler | Analyst unavailable | $42 | $32.63 | -17.2% | Oct 20, 2025 |
| Piper Sandler | Analyst unavailable | $41 | $32.57 | -19.1% | Oct 16, 2025 |
| Bernstein | Guillaume Delaby | $47.6 | $34.12 | -6.1% | Oct 8, 2025 |
| Jefferies | Lloyd Byrne | $51 | $35.47 | +0.6% | Jul 27, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $52 | $34.5 | +2.6% | Jul 16, 2025 |
| UBS | Analyst unavailable | $45 | $35.91 | -11.2% | Jul 2, 2025 |
| Jefferies | Analyst unavailable | $53 | $33.18 | +4.5% | Jun 26, 2025 |
| Raymond James | Analyst unavailable | $43 | $34.1 | -15.2% | Apr 28, 2025 |
| Susquehanna | Charles Minervino | $48 | $33.92 | -5.3% | Apr 14, 2025 |
| Jefferies | Lloyd Byrne | $59 | $42.1 | +16.4% | Mar 27, 2025 |
| Barclays | David Anderson | $61 | $42.43 | +20.3% | Oct 21, 2024 |
| Susquehanna | Bascome Majors | $56 | $42.54 | +10.5% | Oct 21, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $60 | $42.51 | +18.3% | Oct 21, 2024 |
| Citigroup | Scott Gruber | $54 | $42.5 | +6.5% | Oct 21, 2024 |
| Raymond James | James Rollyson | $57 | $41.92 | +12.4% | Oct 21, 2024 |
| Goldman Sachs | Neil Mehta | $52 | $41.92 | +2.6% | Oct 21, 2024 |
| Jefferies | Lloyd Byrne | $68 | $43.94 | +34.1% | Oct 2, 2024 |
| CFRA | Stewart Glickman | $42 | $39.36 | -17.2% | Sep 10, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $65 | $49.68 | +28.2% | Jul 22, 2024 |
| Evercore ISI | James West | $74 | $49.38 | +46.0% | Jul 22, 2024 |
| RBC Capital | Mark Miller | $80 | $23.37 | +57.8% | Jul 15, 2024 |
| RBC Capital | Keith Mackey | $69 | $54.68 | +36.1% | Apr 3, 2024 |
| Societe Generale | Guillaume Delaby | $81 | $52.58 | +59.8% | Dec 22, 2023 |
| Susquehanna | Charles Minervino | $59 | $52.15 | +16.4% | Oct 24, 2022 |
| Bank of America Securities | Chase Mulvehill | $55 | $52.15 | +8.5% | Oct 24, 2022 |
| Wolfe Research | Sam Margolin | $51 | $50.41 | +0.6% | Oct 21, 2022 |
| Evercore ISI | James West | $60 | $50.41 | +18.3% | Oct 21, 2022 |
| Barclays | David Anderson | $59 | $36.64 | +16.4% | Jun 20, 2022 |
| Evercore ISI | James West | $51 | $39.92 | +0.6% | Apr 29, 2022 |
| Barclays | David Anderson | $55 | $39.01 | +8.5% | Apr 29, 2022 |
| HSBC | Abhishek Kumar | $44.2 | $39.95 | -12.8% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $55 | $41.65 | +8.5% | Apr 25, 2022 |
| Piper Sandler | Ian Macpherson | $55 | $43.25 | +8.5% | Apr 14, 2022 |
| Stifel Nicolaus | Stephen Gengaro | $50 | $41.33 | -1.4% | Apr 11, 2022 |
| Goldman Sachs | Neil Mehta | $51 | $42.21 | +0.6% | Mar 30, 2022 |
| Susquehanna | Bascome Majors | $54 | $43.4 | +6.5% | Mar 10, 2022 |
| BNP Paribas | Nick Konstantakis | $45 | $39.8 | -11.2% | Jan 26, 2022 |
| Bank of America Securities | Chase Mulvehill | $44 | $36.49 | -13.2% | Jan 24, 2022 |
| Stephens | Tommy Moll | $45 | $36.49 | -11.2% | Jan 24, 2022 |
| Morgan Stanley | Connor Lynagh | $43 | $36.49 | -15.2% | Jan 24, 2022 |
| J.P. Morgan | Arun Jayaram | $43 | $36.49 | -15.2% | Jan 24, 2022 |
| BMO Capital | Phillip Jungwirth | $43 | $36.49 | -15.2% | Jan 24, 2022 |
| Barclays | David Anderson | $48 | $34.11 | -5.3% | Oct 25, 2021 |
| Oddo BHF | Baptiste Lebacq | $44.5 | $33.28 | -12.2% | Oct 14, 2021 |
| HSBC | Abhishek Kumar | $25 | $27.31 | -50.7% | Aug 4, 2021 |
| Piper Sandler | Ian Macpherson | $31 | $29.12 | -38.9% | Jul 26, 2021 |
Track every rating change on SLB the moment it posts. Free to start.
Start free